TechJournal South
Header

Posts Tagged ‘nanotechnology’

Gates Foundation invests $10M in nanotech firm Liquidia

Friday, March 4th, 2011

LiquidiaRESEARCH TRIANGLE, NC – Liquidia Technologies, a nanotechnology firm, has received a $10 million investment from the Bill & Melinda Gates Foundation. The financing follows Liquidia’s partnership in a global campaign against malaria, one of the Gates’ Foundation’s targets.

Liquidia, founded by UNC-CH and NCSU professor Joseph DeSimone in 2004, became a partner in the global PATH Malaria Vaccine Initiative last month.

The Gates investment will be used for the development of vaccines and therapeutic treatments. Venture-backed Liquidia has raised $25 million.

“We are delighted the Gates Foundation has decided to join an outstanding group of investors that share our confidence in the potential of PRINT technology to improve vaccine delivery and effectiveness,” said Neal Fowler, Liquidia’s CEO. “As the field of vaccines continues to grow, success will be defined by our ability to produce and deliver highly efficacious therapies in quantities and costs that will support the global demand.”

Doug Holtzman, deputy director for the infectious diseases team at the foundation, said, “Funding innovation is a key to addressing the unmet health needs of the world’s poorest people. This unique investment partnership will help us advance vaccine development as part of our commitment to help research, develop and deliver vaccines for the world’s poorest countries.”

Liquidia is developing a nano-manufacturing technology called PRINT, that enable development of precisely engineered particles for use safer and more effiecient delivery of drugs and vaccines.

 

TechJournal South is a TechMedia company. TechMedia presents the annual conferences:

SoutheastVentureConference: www.seventure.org

Internet Summit: www.internetsummit.com

Digital East: www.digitaleast.com

Digital Summit: www.digitalsummit.com

 

 

Maryland-based Pixelligent nabs $425K for nanotech materials

Monday, February 7th, 2011

PixelligentCOLLEGE PARK, MD – Pixelligent Technologies, a company developing nanotechnology applications in optical lithography and nanocomposites for the semiconductor and microelectronics markets, has rasied $425,000 in equity, according to a regulatory filing.

The 2006  former Maryland Incubator of the Year nanotechnology company raised $2 million from angel investors, a West Coast entrepreneur, and the company’s management team in 2009.

Founded in 2000, it has also received $8.2 million in grants from the National Institute of Standards and Technology and the National Science Foundation, which is very significant federal grant money.

The company says its technologies extend the use of current chip manufacturing technology, promising improved performance and cost savings for chip makers.

It has also developed a process to enhance phtoelectrochemical hydrogen production while increasing the reliability of the process. This breakthrough could result in significantly cheaper fuel that could be used in many applications including, powering vehicles.

Raleigh-based Xanofi launches game-changing nanotech fiber product

Wednesday, December 15th, 2010

By Allan Maurer

XanofiRALEIGH, NC – Xanofi, a company introducing a new platform for “faster, cheaper and better” nanofiber production, has launched with serial entrepreneur Miles Wright as founder and CEO.

Wright tells TechJournal South that the five-employee company started in stealth mode in September and is privately funded. The seed round, which is yet to be completed, should take it through next year when it will likely seek a Series A round of funding, says Wright.

Wright has more than 20 years of start-up experience in several fields, including building a 65,000 square foot, 150 person manufacturing plant from the ground up. Wright’s previous successful launches include Accugraphics, Eyebeam, Signature Publishing, and MCW Properties, in addition to developing new technology for CoastMaster.

Wright says that North Carolina has the opportunity to become a leader in nanotechnology. “We could become a center for nanotechnologies,” he says.

Xanofi, using technology derived from seven years of research at North Carolina State University, is offering several nanotech products, including XanoShear, which creates polymeric fibers with shear force in liquids, an inherently simple and efficient design that also accepts a wide range of additives to create functionalized fibers (fibers that have coatings, additives or other enhancements).

Nanofibers have applications in medicine, protective clothing, sensors, filters, batteries, and research. They may one day be woven into clothing to provide power to electronic devices.

Currently, most commercial nanofibers are created by electrospinning and meltblowing, two technologies that are mechanically harsh and require significant energy cost. XanoShear can reduce production energy costs by 75 percent and the overall cost of fiber production by 50 percent, Wright says

Production yields from a single lab prototype machine is over 20 times greater than electrospinning, with research demonstrating possible increases over 100x.

Leading the scientific team is Dr. Orlin Velev, principal investigator in charge of developing the XanoShear process.

In the spring of 2011, Xanofi will begin commercial production of fibers for clients and will seek ISO certification.

“Our business model is to partner with companies that need nanotechnologies incorporated into their products but don’t want the distraction or capital expense of becoming nanofiber production companies themselves,” says Wright.

“By having a process that can produce very high yields of fibers, a wide range of polymers to address the various markets and multiple means of delivery, Xanofi will become an important and trusted supplier that makes enhanced products commercially viable.”

The company name has an interesting origin.

Its Web site describes it this way: “We started with ‘nano’ but felt too many companies have nano in their name. We added the universal mathematics symbol X to signify scalability…Xano. This also reminds us of the Coleridge poem Kubla Khan and the better world of Xanadu. We finished it off with ‘fi’ on the backend because we make fibers. Xanofi – a scalable nanofiber company that wants to make the world a better place.”

The company currently is building large-scale commercial equipment and seeking to identify partners in a variety of industries.

Nasty plant virus leads to small, powerful new battery tech

Monday, December 13th, 2010

University of MarylandCOLLEGE PARK, Md.–Viruses have a bad rep–and rightly so. The ability of a virus to quickly and precisely replicate itself makes it a destructive scourge to animals and plants alike.

Now an interdisciplinary team of researchers at the University of Maryland’s A. James Clark School of Engineering and College of Agriculture and Natural Resources, brought together by Professor Reza Ghodssi, is turning the tables. It is harnessing and exploiting the “self-renewing” and “self-assembling” properties of viruses for a higher purpose: to build a new generation of small, powerful and highly efficient batteries and fuel cells.

The rigid, rod-shaped Tobacco mosaic virus (TMV), which under an electron microscope looks like uncooked spaghetti, is a well-known and widespread plant virus that devastates tobacco, tomatoes, peppers, and other vegetation.

But in the lab, engineers have discovered that they can harness the characteristics of TMV to build tiny components for the lithium ion batteries of the future. They can modify the TMV rods to bind perpendicularly to the metallic surface of a battery electrode and arrange the rods in intricate and orderly patterns on the electrode.

Then, they coat the rods with a conductive thin film that acts as a current collector and finally the battery’s active material that participates in the electrochemical reactions.

New batteries are a leap forward

As a result, the researchers can greatly increase the electrode surface area and its capacity to store energy and enable fast charge/discharge times. TMV becomes inert during the manufacturing process; the resulting batteries do not transmit the virus.

The new batteries, however, have up to a 10-fold increase in energy capacity over a standard lithium ion battery.

“The resulting batteries are a leap forward in many ways and will be ideal for use not only in small electronic devices but in novel applications that have been limited so far by the size of the required battery,” said Ghodssi, director of the Institute for Systems Research and Herbert Rabin Professor of Electrical and Computer Engineering at the Clark School.

“The technology that we have developed can be used to produce energy storage devices for integrated microsystems such as wireless sensors networks. These systems have to be really small in size–millimeter or sub-millimeter–so that they can be deployed in large numbers in remote environments for applications like homeland security, agriculture, environmental monitoring and more; to power these devices, equally small batteries are required, without compromising in performance.”

TMV’s nanostructure is the ideal size and shape to use as a template for building battery electrodes. Its self-replicating and self-assembling biological properties produce structures that are both intricate and orderly, which increases the power and storage capacity of the batteries that incorporate them. Because TMV can be programmed to bind directly to metal, the resulting components are lighter, stronger and less expensive than conventional parts.

“Virus-enabled nanorod structures are tailor-made for increasing the amount of energy batteries can store. They confer an order of magnitude increase in surface area, stabilize the assembled materials and increase conductivity, resulting in up to a10-fold increase in the energy capacity over a standard lithium ion battery,” Chunsheng Wang, a professor in the Department of Chemical and Biomolecular Engineering, said.

The use of the TMV virus in fabricating batteries can be scaled up to meet industrial production needs.

At the same time, very tiny microbatteries can be produced using this technology.

Funding for the research comes from the National Science Foundation, the Department of Energy Office of Basic Energy Sciences, the Maryland Technology Development Corporation, and the Laboratory for Physical Sciences at the University of Maryland. James Culver’s work is conducted in collaboration with Purdue University professor Michael Harris.

COIN seeks materials from NC nanotech firms for DC conference

Wednesday, November 17th, 2010

By Brooks Adam

Brooks Adams

Brooks Adams

The Center of Innovation for Nanobiotechnology (COIN) will be a bronze-level sponsor for the upcoming NNI Nanotechnology Innovation Summit, December 8-10 in Washington DC. It wll also help raise the profile of North Carolina’s nearly 40 nanobiotech and about 50 nanotechnology related firms by bringing along their marketing materials even for those that cannot attend.

COIN is a non-profit that promotes commercialization of nanobiotechnology in North Carolina and beyond. COIN’s programs and services are designed to help accelerate innovation management and new product development.

The upcoming conference celebrates the 10th anniversary of the NNI, and is a gathering of the nation’s top Federal Agencies, Innovators and Investors at the National Nanotechnology Innovation Summit. The Nation’s top nanotech leaders will be showcasing their successes and discussing strategic insights into Nanotechnology challenges and opportunities

COIN will be going there to represent the North Carolina nanobiotech industry and forge relationships to grow the nanobiotech community. If you want our team to help raise the profile of your company because you cannot attend the Summit, please contact clare.valcore@nc-coin.org to  help facilitate getting your materials there. Otherwise, please come by our booth and meet us, as we will be exhibiting. We hope to see many of you there. –

PureLux turns on $1M of $2M raise for next gen lights

Thursday, September 16th, 2010

PureLuxCHARLOTTE, NC  - PureLux Inc., a company selling next generation light sources more efficient than incandescents and fluorescents, has raised $1 million of a $2 million equity raise, according to a regulatory filing.

Investors include Wake Forest University and NanoHoldings of Rowayton, CT. PureLux previously received $100,000 from the NC Green Business Fund in 2009.

The company is a spin-out  from the Center for Nanotechnology and Molecular Materials at Wake Forest University in Winston-Salem, NC.

PureLux is using nano-composite polymer films that surpasses the efficiency of commonly installed lighting devices.

 Unlike incandescent and fluorescent lights, which lose a significant amount of energy to heat, PureLux lighting is extremely efficient in converting energy directly to light.

 PureLux is already 10 times more efficient than incandescent bulbs and 3 times more efficient than common fluorescent bulbs.

The company’s initial product will be a thin-film, plug-compatible replacement for common fluorescent fixtures that not only reduces energy consumption but also produces light of improved color, warmth and appearance.

This new lighting system will be compatible with current electrical circuitry in offices, homes, factories and other facilities.

It disclosed the raise in a filing with the US Securities and Exchange Commission.

We didn’t find a Web site for the firm.

NC Nanobiotechnology Center makes the ultra small a big deal

Thursday, September 9th, 2010

Brooks Adams

Brooks Adams, executive director, COIN

RESEARCH TRIANGLE PARK, NC – The new NC Center of Innovation for Nanobiotechnology (COIN), a non profit organization funded by a four-year $2.5 million grant from the NC Biotechnology Center, plans to help increase commercialization of nanobio technologies in the state.

Nanotechnology deals with the world of the ultra-small on the atomic or molecular scale. A nanometer is one-billionth of a meter. The diameter of a water molecule  is about 3 nanometers. How small is a molecule? There are as many molecules in a teaspoon of water as there are teaspoons of water in the ocean.

“North Carolina is already a leader in nanobiology technologies,” says Brooks Adams, executive director of the Center. “The opportunity for the state is significant. There is already burgeoning small company activity spawned largely from university settings.”

There are 35 nanobio related institutes in public and private institutions in the state Adams says and a growing number of nanobio companies. “We have identified 37 nanobio companies, a lot of them new.”

The COIN website profiles a handful of those, including:

Pioneer Surgical Orthobiologic, which has an FDA-approved and clinically available nano-enabled tissue engineering product.

Peptagen an R&D-stage company developing a novel vaccine technology, in search of a nano-delivery vector.

Inanovate launched nano-enabled research tools based on nanoscale surface technologies and are developing a clinical diagnostics platform.

Advanced Liquid Logic is in advanced development for a next-generation microfluidics device that can manipulate nanoliter droplets.

TechJournal South has reported on most of these and numerous other nanobio firms, where, Adams points out, some of the major coming advances are in areas such as targeted drug delivery. Raleigh-based Nanovector, which we profiled in the past, is one (See: Nanovector virus may solve nanoparticle drug delivery problems).

“A lot of these new approaches are looking like they are going to work,” Adams notes.

COIN will operate statewide with an emphasis on clusters of nanobiotechnology assets and activity within the Charlotte, Piedmont Triad, and Research Triangle metropolitan areas.

These assets  include public and private research institutes, major academic medical  centers, as well as emerging and large companies active in key sectors where  nanobiotechnology will have significant commercial impact, and investors and others with vested interest in the field.

COIN plans its inaugural Nanobiotechnology Executive Roundtable event, aimed at getting various players and stake holders in the nanobiotechnology sector together, Sept. 22 at the Research Triangle Park Foundation headquarters at 12 Davis Drive. — Allan Maurer

To contact TechJournal South Editor & Writer Allan Maurer: Allan at TechJournalSouth dot com.

See also: Jim Roberts joins new Nanobiotechnology Center

New Nanotech school opens in Greensboro

Monday, August 23rd, 2010

nanotech schoolGREENSBORO, NC – North Carolina A&T State University and the University of North Carolina at Greensboro are jointly operating the Joint School of Nanotechnology and Nanoengineering that opens today (Monday, Aug.23). It is one of only ten such schools nationally.

Nanotechnology deals with atoms and molecules 1,000 times smaller than the width of a human hair. It has wide applications in medicine, IT, materials science and new product development.

The new school is intended to provide undergraduates and high school students access to understanding the field and training for scientists and engineers already in the workforce.

James Ryan, a former IBM exec who holds 47 patents, has been named dean of the school.

We have reported recently on startups with nanoparticle technologies, medical uses of nanobots that track down and kill infections, and other uses of this  technology of the ultra tiny sub microscopic world.

See:

Tiny nanofactories may stop infections without antibiotics

Parabon Nanolabs targets tumor cells

Nanoparticle “fingerprint” predicts biological interactions

Humble protein, nanoparticles partner to kill cancer cells

Blue Nano materials make better fuel cells, batteries and solar products

Jim Roberts joins Nanobiotechnology center

Tuesday, August 17th, 2010

Jim Roberts

Jim Roberts

RALEIGH, NC – James (Jim) Roberts, well known in North Carolina for his roles in technology economic development and entrepreneurial support organizations, has joined the Center of Innovation in Nanobiotechnology as director of membership services and fundraising.

Most recently, Roberts served as a business development manager for the International Trade Division, North Carolina Department of Commerce where he was responsible for helping North Carolina nanotechnology, alternative energy, information technology and aerospace companies sell to developing international markets.

Roberts was founder and executive director of Blue Ridge Entrepreneurial Council (BREC) and Blue Ridge Angel Investors Network (BRAIN) in Asheville, NC.

Roberts was also founder of FirstRound, an entrepreneur support organization based in Charlotte that expanded to Greensboro, Raleigh, Asheville and Greenville, SC.

We first met Roberts a decade ago when he was just forming FirstRound and we were reporting for one of the Internet’s first tech business oriented daily news sites. His energy and dedication to making things happen was evident and never seemed to flag despite two economic downturns since.

COIN helps accelerate new product development

COIN is a non-profit that promotes commercialization of nanobiotechnology in North Carolina and beyond. The opportunity represented by the myriad applications of nanobiotechnology in key life science and medical product sectors for the state is significant.

COIN’s programs and services are designed to help researchers, entrepreneurs, product developers, business managers, and investors involved in nanobiotechnology to accelerate innovation management and new product development.

In his new role, Roberts will develop industry, university, foundation, and individual participation in and support for COIN’s initiatives.  Roberts will also take the lead in evaluating and launching a program offering assistance to nanomedicine companies in identifying and accessing pre-clinical testing services.

“We are delighted to have Jim Roberts on board.  Having started two entrepreneur development organizations and a successful angel investor network, Jim is qualified to help COIN evolve and grow as a client-driven organization,” said Brooks Adams, executive director & president of COIN.

To contact TechJournal South Editor & Writer Allan Maurer: Allan at TechJournalSouth dot com.

Nanoparticle “fingerprint” predicts biological interactions

Tuesday, August 17th, 2010

NCSURALEIGH, NC – Researchers at North Carolina State University have developed a method for predicting the ways nanoparticles will interact with biological systems – including the human body. Their work could have implications for  improved human and environmental safety in the handling of nanomaterials, as well as applications for drug delivery.

The researchers wanted to create a method for the biological characterization of nanoparticles – a screening tool that would allow other scientists to see how various nanoparticles might react when inside the body.

“We wanted to find a good, biologically relevant way to determine how nanomaterials react with cells,” Dr. Jim Riviere says. “When a nanomaterial enters the human body, it immediately binds to various proteins and amino acids. The molecules a particle binds with will determine where it will go.”

This binding process also affects the particle’s behavior inside the body. According to Monteiro-Riviere, the amino acids and proteins that coat a nanoparticle change its shape and surface properties, potentially enhancing or reducing characteristics like  toxicity or, in medical applications, the particle’s ability to deliver drugs to targeted cells.

Fingerprinting a nanoparticle

To create their screening tool, the team utilized a series of chemicals to probe the surfaces of various nanoparticles, using techniques previously developed by Dr. Xin-RuiXia.

A nanoparticle’s size and surface characteristics determine the kinds of materials with which it will bond. Once the size and surface  characteristics are known, the researchers can then create “fingerprints” that identify the ways that a particular particle will interact with biological molecules.

These fingerprints allow them to predict how that nanoparticle might behave once inside the body.

The study results appear in the Aug. 15 online edition of Nature Nanotechnology.

“This information will allow us to predict where a particular nanomaterial will end up in the human body, and whether or not it will be taken up by certain cells,” Riviere adds. “That in turn will give us a better idea of which nanoparticles may be useful for drug delivery, and which ones may be hazardous to humans or the environment.”

NC State researchers Riviere, Burroughs Wellcome Distinguished Professor of  Pharmacology and director of the university’s Center for Chemical Toxicology Research and Pharmacokinetics, Dr. Nancy Monteiro-Riviere, professor of investigative dermatology and toxicology, and  Xia, research assistant professor of pharmacology, conducted the study.